James W. Newman Jr. - May 29, 2025 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ James W. Newman, Jr.
Stock symbol
ADIL
Transactions as of
May 29, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 04:01 PM
Previous filing
Mar 27, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Newman James W. Jr. Director 4870 SADLER ROAD,, STE 300, GLEN ALLEN, /s/ James W. Newman, Jr. 2025-06-02 0001718364

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +28K $0.00 28K May 29, 2025 Common Stock 28K $0.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025.